These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11212702)

  • 1. [Omenn syndrome].
    Yachie A
    Ryoikibetsu Shokogun Shirizu; 2000; (32):23-6. PubMed ID: 11212702
    [No Abstract]   [Full Text] [Related]  

  • 2. GvHD-associated cytokine polymorphisms do not associate with Omenn syndrome rather than T-B- SCID in patients with defects in RAG genes.
    Haq IJ; Steinberg LJ; Hoenig M; van der Burg M; Villa A; Cant AJ; Middleton PG; Gennery AR
    Clin Immunol; 2007 Aug; 124(2):165-9. PubMed ID: 17572155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders.
    Wada T; Takei K; Kudo M; Shimura S; Kasahara Y; Koizumi S; Kawa-Ha K; Ishida Y; Imashuku S; Seki H; Yachie A
    Clin Exp Immunol; 2000 Jan; 119(1):148-55. PubMed ID: 10606976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation.
    Hönig M; Schwarz K
    Curr Opin Rheumatol; 2006 Jul; 18(4):383-8. PubMed ID: 16763459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome.
    Roifman CM; Gu Y; Cohen A
    J Allergy Clin Immunol; 2006 Apr; 117(4):897-903. PubMed ID: 16630949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombination activating gene and its defects.
    Villa A; Sobacchi C; Vezzoni P
    Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):491-5. PubMed ID: 11964731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome.
    Corneo B; Moshous D; Güngör T; Wulffraat N; Philippet P; Le Deist FL; Fischer A; de Villartay JP
    Blood; 2001 May; 97(9):2772-6. PubMed ID: 11313270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation in severe combined immunodeficiency: potential and current limitations.
    Friedrich W; Knobloch C; Greher J; Hartmann W; Peter HH; Goldmann SF; Kleihauer E
    Immunodeficiency; 1993; 4(1-4):315-22. PubMed ID: 8167725
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel RAG1 mutation in a case of severe combined immunodeficiency.
    Zhang J; Quintal L; Atkinson A; Williams B; Grunebaum E; Roifman CM
    Pediatrics; 2005 Sep; 116(3):e445-9. PubMed ID: 16061569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omenn syndrome: a rare case of neonatal erythroderma.
    Puzenat E; Rohrlich P; Thierry P; Girardin P; Taghian M; Ouachee M; Plouvier E; Fischer A; Humbert P; Aubin F
    Eur J Dermatol; 2007; 17(2):137-9. PubMed ID: 17337397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of autoimmune hemolytic anemia with rituximab in a child with severe combined immunodeficiency following nonidentical T-cell-depleted bone marrow transplantation.
    Bonduel M; Zelazko M; Figueroa C; Magaldi G; Rossi J; del Pozo A
    Bone Marrow Transplant; 2005 Apr; 35(8):819-21. PubMed ID: 15750606
    [No Abstract]   [Full Text] [Related]  

  • 13. RAG-dependent primary immunodeficiencies.
    Sobacchi C; Marrella V; Rucci F; Vezzoni P; Villa A
    Hum Mutat; 2006 Dec; 27(12):1174-84. PubMed ID: 16960852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial V(D)J recombination activity leads to Omenn syndrome.
    Villa A; Santagata S; Bozzi F; Giliani S; Frattini A; Imberti L; Gatta LB; Ochs HD; Schwarz K; Notarangelo LD; Vezzoni P; Spanopoulou E
    Cell; 1998 May; 93(5):885-96. PubMed ID: 9630231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access roads for RAG-ged terrains: control of T cell receptor gene rearrangement at multiple levels.
    Livák F; Petrie HT
    Semin Immunol; 2002 Oct; 14(5):297-309. PubMed ID: 12220931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Purine nucleoside phosphorylase deficiency].
    Sakiyama Y
    Ryoikibetsu Shokogun Shirizu; 2000; (32):43-5. PubMed ID: 11212766
    [No Abstract]   [Full Text] [Related]  

  • 17. V(D)J recombination.
    Schatz DG
    Immunol Rev; 2004 Aug; 200():5-11. PubMed ID: 15242391
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency.
    Kumaki S; Villa A; Asada H; Kawai S; Ohashi Y; Takahashi M; Hakozaki I; Nitanai E; Minegishi M; Tsuchiya S
    Blood; 2001 Sep; 98(5):1464-8. PubMed ID: 11520796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary CD7 deficiency].
    Yasukawa M
    Ryoikibetsu Shokogun Shirizu; 2000; (32):112-3. PubMed ID: 11212657
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow transplantation without conditioning regimen in Omenn syndrome: a case report.
    Mellouli F; Torjmen L; Ksouri H; Abdelkefi A; Ladab S; Barbouche R; Othman TB; Hassen AB; Bejaoui M
    Pediatr Transplant; 2007 Dec; 11(8):922-6. PubMed ID: 17976129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.